Skip to main content
Erschienen in: Wiener Medizinische Wochenschrift 21-22/2012

01.11.2012 | main topic

Diagnosis of anaemia: old things rearranged

verfasst von: Prim. Univ.-Prof. Dr. Gabriele Halwachs-Baumann, MSc, MBA

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 21-22/2012

Einloggen, um Zugang zu erhalten

Summary

Anaemia is one of the most leading causes of morbidity and mortality, as declared by the World Health Organisation. This syndrome is characterised by low haemoglobin levels and nonspecific clinical symptoms such as weakness, fatigue and dyspnoea. The symptoms are unspecific as the underlying causes are heterogeneous. Thus, good knowledge of the useful bisickomarkers and their correct assignment is needed to allow rapid and targeted diagnosis.
Fußnoten
1
Serum transferrin (TF) (g/l) = 0.007 ´ Total iron-binding capacity (TIBC) (mg/l)
TIBC (mg/dl) = TF (mg/dl) ´ 1.41
TIBC (mmol/l) = TF (g/l) ´ 25.2
Transferrin saturation (TSAT) (%) = serum iron (mg/dl)/TF (mg/dl) ´ 70.9
TSAT (%) = serum iron (mmol/l)/TF (mg/dl) ´ 398
 
Literatur
1.
Zurück zum Zitat World Health Organization. Nutritional anaemias: report of a WHO scientific group. WHO Tech Rep Ser. 1968;405:1–40. World Health Organization. Nutritional anaemias: report of a WHO scientific group. WHO Tech Rep Ser. 1968;405:1–40.
2.
Zurück zum Zitat Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood haemoglobin concentration? Blood. 2006;107:1747–50.PubMedCrossRef Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood haemoglobin concentration? Blood. 2006;107:1747–50.PubMedCrossRef
3.
Zurück zum Zitat Rushton DH, Dover R, Sainsbury AW, et al. Why should women have lower reference limits for haemoglobin and ferritin concentrations than men? BMJ. 2001;322:1355–7.PubMedCrossRef Rushton DH, Dover R, Sainsbury AW, et al. Why should women have lower reference limits for haemoglobin and ferritin concentrations than men? BMJ. 2001;322:1355–7.PubMedCrossRef
4.
Zurück zum Zitat Waalen J, Felitti V, Beutler E. Haemoglobin and ferritin concentrations in men and women: cross sectional study. BMJ. 2002;325:137. Waalen J, Felitti V, Beutler E. Haemoglobin and ferritin concentrations in men and women: cross sectional study. BMJ. 2002;325:137.
5.
Zurück zum Zitat Milman N, Pedersen AN, Ovesen L, et al. Hemoglobin concentrations in 358 apparently healthy 80-year-old Danish men and women. Should the reference interval be adjusted for age? Aging Clin Exp Res. 2008;20:8–14.PubMed Milman N, Pedersen AN, Ovesen L, et al. Hemoglobin concentrations in 358 apparently healthy 80-year-old Danish men and women. Should the reference interval be adjusted for age? Aging Clin Exp Res. 2008;20:8–14.PubMed
6.
Zurück zum Zitat Cheng CK, Chan J, Cembrowski GS, et al. Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex and race. Lab Hematol. 2004;10:42–53.PubMedCrossRef Cheng CK, Chan J, Cembrowski GS, et al. Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex and race. Lab Hematol. 2004;10:42–53.PubMedCrossRef
7.
Zurück zum Zitat Navaneethan SD, Bonifati C, Schena FP, et al. Evidence for optimal hemoglobin targets in chronic kidney disease. J Nephrol. 2006;19:640–7.PubMed Navaneethan SD, Bonifati C, Schena FP, et al. Evidence for optimal hemoglobin targets in chronic kidney disease. J Nephrol. 2006;19:640–7.PubMed
8.
Zurück zum Zitat Dicato M. Venous thromboembolic events and erythropoiesis-stimulating agents: an update. Oncologist. 2008;13:11–5.PubMedCrossRef Dicato M. Venous thromboembolic events and erythropoiesis-stimulating agents: an update. Oncologist. 2008;13:11–5.PubMedCrossRef
9.
Zurück zum Zitat Pirker R. Erythropoiesis-stimulating agents in patients with cancer: update on safety issues. Expert Opin Drug Saf. 2009;8:515–22.PubMedCrossRef Pirker R. Erythropoiesis-stimulating agents in patients with cancer: update on safety issues. Expert Opin Drug Saf. 2009;8:515–22.PubMedCrossRef
10.
Zurück zum Zitat Al Diab Al. Cancer-related venous thromboembolism: insight into underestimated risk factors. Hematol Oncol Stem Cell Ther. 2010;3:191–5.PubMed Al Diab Al. Cancer-related venous thromboembolism: insight into underestimated risk factors. Hematol Oncol Stem Cell Ther. 2010;3:191–5.PubMed
11.
Zurück zum Zitat Mimoz O, Frasca D, Médard A, et al. Reliability of the HemoCue® hemoglobinometer in critically ill patients: a prospective observational study. Minerva Anestesiol. 2011;77:979–85.PubMed Mimoz O, Frasca D, Médard A, et al. Reliability of the HemoCue® hemoglobinometer in critically ill patients: a prospective observational study. Minerva Anestesiol. 2011;77:979–85.PubMed
12.
Zurück zum Zitat Moreno Chulilla JA, Romero Colás MS, Gutiérrez Martin M. Classification of anemia for gastroenterologists. World J Gastroenterol. 2009;15:4627–37.PubMedCrossRef Moreno Chulilla JA, Romero Colás MS, Gutiérrez Martin M. Classification of anemia for gastroenterologists. World J Gastroenterol. 2009;15:4627–37.PubMedCrossRef
13.
Zurück zum Zitat Hercberg S, Preziosi P, Galan P. Iron deficiency in Europe. Public Health Nutr. 2001;4:537–45.PubMedCrossRef Hercberg S, Preziosi P, Galan P. Iron deficiency in Europe. Public Health Nutr. 2001;4:537–45.PubMedCrossRef
14.
15.
Zurück zum Zitat Kohne E, Kleihauer E. Hämoglobinopathien—eine Langzeitstudie über vier Jahrzehnte. Dtsch Ärztebl Int. 2010;107:65–71.PubMed Kohne E, Kleihauer E. Hämoglobinopathien—eine Langzeitstudie über vier Jahrzehnte. Dtsch Ärztebl Int. 2010;107:65–71.PubMed
16.
Zurück zum Zitat Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5:11. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5:11.
17.
Zurück zum Zitat Koulaouzidis A, Said E, Cottier R, et al. Soluble Transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. J Gastrointestin Liver Dis. 2009;18:345–52.PubMed Koulaouzidis A, Said E, Cottier R, et al. Soluble Transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. J Gastrointestin Liver Dis. 2009;18:345–52.PubMed
18.
Zurück zum Zitat Beris P, Munoz M, Garcia-Erce JA, et al. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth. 2008;100:599–604.PubMedCrossRef Beris P, Munoz M, Garcia-Erce JA, et al. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth. 2008;100:599–604.PubMedCrossRef
19.
Zurück zum Zitat Oppenheimer SJ. Iron and its relation to immunity and infectious disease. J Nutr. 2001;131:616S–35S.PubMed Oppenheimer SJ. Iron and its relation to immunity and infectious disease. J Nutr. 2001;131:616S–35S.PubMed
20.
Zurück zum Zitat Gasche C, Lomer MCE, Cavill I, et al. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53:1190–7.PubMedCrossRef Gasche C, Lomer MCE, Cavill I, et al. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53:1190–7.PubMedCrossRef
21.
Zurück zum Zitat Dale JC, Burritt MF, Zinsmeister AR. Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels. Am J Clin Pathol. 2002;117:802–8.PubMedCrossRef Dale JC, Burritt MF, Zinsmeister AR. Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels. Am J Clin Pathol. 2002;117:802–8.PubMedCrossRef
22.
Zurück zum Zitat Heimpel H, Riedel M, Wennauer R, et al. Die Plasmaeisenbestimmung – nützlich, unnötig oder irreführend? Med Klin. 2003;98:104–7.CrossRef Heimpel H, Riedel M, Wennauer R, et al. Die Plasmaeisenbestimmung – nützlich, unnötig oder irreführend? Med Klin. 2003;98:104–7.CrossRef
23.
Zurück zum Zitat Adams PC, Reboussin DM, Press RD, et al. Biological variability of transferrin saturation and unsaturated iron binding capacity. Am J Med. 2007;120:999.e1–7. Adams PC, Reboussin DM, Press RD, et al. Biological variability of transferrin saturation and unsaturated iron binding capacity. Am J Med. 2007;120:999.e1–7.
24.
Zurück zum Zitat Kasvosve I, Delanghe J. Total iron binding capacity and transferrin concentration in the assessment of iron status. Clim Chem Lab Med. 2002;40:1014–8. Kasvosve I, Delanghe J. Total iron binding capacity and transferrin concentration in the assessment of iron status. Clim Chem Lab Med. 2002;40:1014–8.
25.
Zurück zum Zitat Coyne D. Iron indices: what do they really mean? Kidney Int. 2006;69:S4–8.CrossRef Coyne D. Iron indices: what do they really mean? Kidney Int. 2006;69:S4–8.CrossRef
26.
Zurück zum Zitat Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006;1:S4–8.PubMedCrossRef Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006;1:S4–8.PubMedCrossRef
27.
28.
Zurück zum Zitat Formanowicz D, Formanowicz P. Transferrin changes in haemodialysed patients. Int Urol Nephrol. 2012;44:907–19.PubMedCrossRef Formanowicz D, Formanowicz P. Transferrin changes in haemodialysed patients. Int Urol Nephrol. 2012;44:907–19.PubMedCrossRef
29.
Zurück zum Zitat Northrop-Clewes CA. Interpreting indicators of iron status during an acute phase response—lessons from malaria and human immunodeficiency virus. Ann Clin Biochem. 2008;45:18–32.PubMedCrossRef Northrop-Clewes CA. Interpreting indicators of iron status during an acute phase response—lessons from malaria and human immunodeficiency virus. Ann Clin Biochem. 2008;45:18–32.PubMedCrossRef
30.
Zurück zum Zitat Van Vranken M. Evaluation of microcytosis. Am Fam Physician. 2010;82:1117–22.PubMed Van Vranken M. Evaluation of microcytosis. Am Fam Physician. 2010;82:1117–22.PubMed
31.
Zurück zum Zitat Arosio P, Levi S. Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim Biophys Acta. 2010;1800:783–92.PubMedCrossRef Arosio P, Levi S. Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim Biophys Acta. 2010;1800:783–92.PubMedCrossRef
32.
Zurück zum Zitat Arosio P, Ingrassia R, Cavadini P. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta. 2009;1790:589–99.PubMedCrossRef Arosio P, Ingrassia R, Cavadini P. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta. 2009;1790:589–99.PubMedCrossRef
33.
Zurück zum Zitat Cook JD, Lipschitz DA, Miles LEM, et al. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr. 1974;27:681–7.PubMed Cook JD, Lipschitz DA, Miles LEM, et al. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr. 1974;27:681–7.PubMed
34.
Zurück zum Zitat Addison GM, Jacobs A, Walwalters GO, et al. Ferritin in serum. Lancet. 1973;20:154–5.CrossRef Addison GM, Jacobs A, Walwalters GO, et al. Ferritin in serum. Lancet. 1973;20:154–5.CrossRef
35.
Zurück zum Zitat Jacobs A, Worwood M. Ferritin in serum. Clinical and biochemical implications. N Engl J Med. 1975;292:951–6.PubMedCrossRef Jacobs A, Worwood M. Ferritin in serum. Clinical and biochemical implications. N Engl J Med. 1975;292:951–6.PubMedCrossRef
36.
Zurück zum Zitat Jacobs A, Miller F, Worwood M, et al. Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. Br Med J. 1972;4:206–8.PubMedCrossRef Jacobs A, Miller F, Worwood M, et al. Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. Br Med J. 1972;4:206–8.PubMedCrossRef
37.
Zurück zum Zitat Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med. 1974;290:1213–6.PubMedCrossRef Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med. 1974;290:1213–6.PubMedCrossRef
38.
Zurück zum Zitat Munoz M, Villar I, Garcia-Erce JA. An update on iron physiology. World J Gastroenterol. 2009;15:4617–26.PubMedCrossRef Munoz M, Villar I, Garcia-Erce JA. An update on iron physiology. World J Gastroenterol. 2009;15:4617–26.PubMedCrossRef
39.
Zurück zum Zitat Hallberg L, Bengtsson C, Lapidus L, et al. Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol. 1993;85:787–98.PubMedCrossRef Hallberg L, Bengtsson C, Lapidus L, et al. Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol. 1993;85:787–98.PubMedCrossRef
40.
Zurück zum Zitat Stancu S, Stanciu A, Zugravu A, et al. Bone marrow iron, iron indices, and the response to intravenous iron in patients with non-dialysis-dependent CKD. Am J Kidney Dis. 2010;55:639–47.PubMedCrossRef Stancu S, Stanciu A, Zugravu A, et al. Bone marrow iron, iron indices, and the response to intravenous iron in patients with non-dialysis-dependent CKD. Am J Kidney Dis. 2010;55:639–47.PubMedCrossRef
41.
Zurück zum Zitat Rushton DH, Barth JH. What is the evidence for gender differences in ferritin and haemoglobin? Crit Rev Oncol Hematol. 2010;73:1–9.PubMedCrossRef Rushton DH, Barth JH. What is the evidence for gender differences in ferritin and haemoglobin? Crit Rev Oncol Hematol. 2010;73:1–9.PubMedCrossRef
42.
Zurück zum Zitat Ruddell RG, Hoang-Le D, Barwood JM, et al. Ferritin functions as a proinflammatory cytokine via iron-independent PKC-z/NFkB-regulated signalling in rat hepatic stellate cells. Hepatology. 2009;49:887–900.PubMedCrossRef Ruddell RG, Hoang-Le D, Barwood JM, et al. Ferritin functions as a proinflammatory cytokine via iron-independent PKC-z/NFkB-regulated signalling in rat hepatic stellate cells. Hepatology. 2009;49:887–900.PubMedCrossRef
43.
Zurück zum Zitat Wang W, Knovich MA, Coffman LG, et al. Serum ferritin: past, present and future. Biochim Biophys Acta. 2010;1800:760–9.PubMedCrossRef Wang W, Knovich MA, Coffman LG, et al. Serum ferritin: past, present and future. Biochim Biophys Acta. 2010;1800:760–9.PubMedCrossRef
44.
Zurück zum Zitat Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood. 2010;116:4754–61.PubMedCrossRef Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood. 2010;116:4754–61.PubMedCrossRef
45.
Zurück zum Zitat Ong KH, Tan HL, Lai HC, et al. Accuracy of various parameters in the prediction of iron deficiency in an acute care hospital. Ann Acad Med Singapore. 2005;34:437–40.PubMed Ong KH, Tan HL, Lai HC, et al. Accuracy of various parameters in the prediction of iron deficiency in an acute care hospital. Ann Acad Med Singapore. 2005;34:437–40.PubMed
46.
Zurück zum Zitat Koulaouzidis A, Cottier R, Bhat S, et al. A ferritin level > 50 mg/L is frequently consistent with iron deficiency. Eur J Intern Med. 2009;20:168–70.PubMedCrossRef Koulaouzidis A, Cottier R, Bhat S, et al. A ferritin level > 50 mg/L is frequently consistent with iron deficiency. Eur J Intern Med. 2009;20:168–70.PubMedCrossRef
47.
Zurück zum Zitat Feelders RA, Kuiper-Kramer EPA, van Eijk HG. Structure, function and clinical significance of transferrin receptors. Clin Chem Lab Med. 1999;37:1–10.PubMedCrossRef Feelders RA, Kuiper-Kramer EPA, van Eijk HG. Structure, function and clinical significance of transferrin receptors. Clin Chem Lab Med. 1999;37:1–10.PubMedCrossRef
48.
Zurück zum Zitat Speeckaert MM, Speeckaert R, Delanghe JR. Biological and clinical aspects of soluble transferrin receptor. Crit Rev Clin Lab Sci. 2011;47:213–28.CrossRef Speeckaert MM, Speeckaert R, Delanghe JR. Biological and clinical aspects of soluble transferrin receptor. Crit Rev Clin Lab Sci. 2011;47:213–28.CrossRef
49.
Zurück zum Zitat Munoz M, Garcia-Erce JA, Remacha AF. Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis. J Clin Pathol. 2011;64:281–6.PubMedCrossRef Munoz M, Garcia-Erce JA, Remacha AF. Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis. J Clin Pathol. 2011;64:281–6.PubMedCrossRef
50.
Zurück zum Zitat Ohnishi K, Torimoto Y, Ikuta K, et al. Detection of soluble HFE associated with soluble transferrin receptor in human serum. Int J Mol Med. 2011;27:435–9.PubMed Ohnishi K, Torimoto Y, Ikuta K, et al. Detection of soluble HFE associated with soluble transferrin receptor in human serum. Int J Mol Med. 2011;27:435–9.PubMed
52.
Zurück zum Zitat Thorpe SJ. The development and role of international biological reference materials in the diagnosis of anaemia. Biologicals. 2010;38:449–58.PubMedCrossRef Thorpe SJ. The development and role of international biological reference materials in the diagnosis of anaemia. Biologicals. 2010;38:449–58.PubMedCrossRef
53.
Zurück zum Zitat Thorpe SJ, Heath A, Sharp G, et al. A WHO reference reagent for the serum transferrin receptor (sTfR): international collaborative study to evaluate a recombinant soluble transferrin receptor preparation. Clin Chem Lab Med. 2010;48:815–20.PubMedCrossRef Thorpe SJ, Heath A, Sharp G, et al. A WHO reference reagent for the serum transferrin receptor (sTfR): international collaborative study to evaluate a recombinant soluble transferrin receptor preparation. Clin Chem Lab Med. 2010;48:815–20.PubMedCrossRef
54.
Zurück zum Zitat Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem. 2002;48:1066–76.PubMed Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem. 2002;48:1066–76.PubMed
55.
Zurück zum Zitat Phiri KS, Calis JCJ, Siyasiya A, et al. New cut-off values for ferritin and soluble transferrin receptor for the assessment of iron deficiency in children in a high infection pressure area. J Clin Pathol. 2009;62:1103–6.PubMedCrossRef Phiri KS, Calis JCJ, Siyasiya A, et al. New cut-off values for ferritin and soluble transferrin receptor for the assessment of iron deficiency in children in a high infection pressure area. J Clin Pathol. 2009;62:1103–6.PubMedCrossRef
56.
Zurück zum Zitat Yang Z, Dewey KG, Lönnerdal B, et al. Comparison of plasma ferritin concentration with the ratio of plasma transferrin receptor to ferritin in estimating body iron stores: results of 4 intervention trials. Am J Clin Nutr. 2008;87:1892–8.PubMed Yang Z, Dewey KG, Lönnerdal B, et al. Comparison of plasma ferritin concentration with the ratio of plasma transferrin receptor to ferritin in estimating body iron stores: results of 4 intervention trials. Am J Clin Nutr. 2008;87:1892–8.PubMed
57.
Zurück zum Zitat Skikne BS, Punnonen K, Caldron PH, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicentre evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol. 2011;86:923–7.PubMedCrossRef Skikne BS, Punnonen K, Caldron PH, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicentre evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol. 2011;86:923–7.PubMedCrossRef
58.
Zurück zum Zitat Rimon E, Levy S, Sapir A, et al. Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index. Arch Intern Med. 2002;162:445–9.PubMedCrossRef Rimon E, Levy S, Sapir A, et al. Diagnosis of iron deficiency anemia in the elderly by transferrin receptor-ferritin index. Arch Intern Med. 2002;162:445–9.PubMedCrossRef
59.
Zurück zum Zitat Genc S, Erten N, Karan MA, et al. Soluble transferrin receptor and soluble transferrin receptor-ferritin index for evaluation of the iron status in elderly patients. Tohoku J Exp Med. 2004;202:135–42.PubMedCrossRef Genc S, Erten N, Karan MA, et al. Soluble transferrin receptor and soluble transferrin receptor-ferritin index for evaluation of the iron status in elderly patients. Tohoku J Exp Med. 2004;202:135–42.PubMedCrossRef
60.
Zurück zum Zitat Munoz M, Garcia-Erce JA, Remacha AF. Disorders of iron metabolism. Part II: iron deficiency and iron overload. J Clin Pathol. 2011;64:287–96.PubMedCrossRef Munoz M, Garcia-Erce JA, Remacha AF. Disorders of iron metabolism. Part II: iron deficiency and iron overload. J Clin Pathol. 2011;64:287–96.PubMedCrossRef
61.
Zurück zum Zitat Leers MPG, Keuren JFW, Oosterhuis WP. The value of the Thomas-plot in the diagnostic work up of anemic patients referred by general practitioners. Int J Lab Hematol. 2010;32:572–81.PubMedCrossRef Leers MPG, Keuren JFW, Oosterhuis WP. The value of the Thomas-plot in the diagnostic work up of anemic patients referred by general practitioners. Int J Lab Hematol. 2010;32:572–81.PubMedCrossRef
62.
Zurück zum Zitat Thomas C, Kirschbaum A, Boehm D, et al. The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy. Med Oncol. 2006;23:23–36.PubMedCrossRef Thomas C, Kirschbaum A, Boehm D, et al. The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy. Med Oncol. 2006;23:23–36.PubMedCrossRef
63.
Zurück zum Zitat Thomas C, Thomas L. Anemia of chronic disease: pathophysiology and laboratory diagnosis. Lab Hematol. 2005;11:14–23.PubMedCrossRef Thomas C, Thomas L. Anemia of chronic disease: pathophysiology and laboratory diagnosis. Lab Hematol. 2005;11:14–23.PubMedCrossRef
64.
Zurück zum Zitat Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem. 2003;49:1573–8.PubMedCrossRef Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem. 2003;49:1573–8.PubMedCrossRef
65.
Zurück zum Zitat Steinmetz HT, Tsamaloukas A, Schmitz S, et al. A new concept fort the differential diagnosis and therapy of anaemia in cancer patients. Support Care Cancer. 2010;19:261–9.PubMedCrossRef Steinmetz HT, Tsamaloukas A, Schmitz S, et al. A new concept fort the differential diagnosis and therapy of anaemia in cancer patients. Support Care Cancer. 2010;19:261–9.PubMedCrossRef
66.
Zurück zum Zitat Katodritou E, Speletas M, Zervas K, et al. Evaluation of hypochromic erythrocytes in combination with sTfR-F index for predicting response to r-HuEPO in anemic patients with multiple myeloma. Lab Hematol. 2006;12:47–54.PubMedCrossRef Katodritou E, Speletas M, Zervas K, et al. Evaluation of hypochromic erythrocytes in combination with sTfR-F index for predicting response to r-HuEPO in anemic patients with multiple myeloma. Lab Hematol. 2006;12:47–54.PubMedCrossRef
67.
68.
Zurück zum Zitat Thomas C, Kobold U, Thomas L. Serum hepcidin-25 in comparison to biochemical markers and haematological indices for the differentiation of iron-restricted erythropoiesis. Clin Chem Lab Med. 2011;49:207–13.PubMedCrossRef Thomas C, Kobold U, Thomas L. Serum hepcidin-25 in comparison to biochemical markers and haematological indices for the differentiation of iron-restricted erythropoiesis. Clin Chem Lab Med. 2011;49:207–13.PubMedCrossRef
69.
Zurück zum Zitat Ganz T. Hepcidin in its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program. 2006;507:29–35.CrossRef Ganz T. Hepcidin in its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program. 2006;507:29–35.CrossRef
71.
Zurück zum Zitat Pasricha SR, McQuilten Z, Westerman M, et al. Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica. 2011;96:1099–105.PubMedCrossRef Pasricha SR, McQuilten Z, Westerman M, et al. Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica. 2011;96:1099–105.PubMedCrossRef
72.
Zurück zum Zitat Thomas C, Kobold U, Balan S, et al. Serum hepcidin-25 may replace the ferritin index in the Thomas plot in assessing iron status in anemic patients. Int J Lab Hem. 2011;33:187–93.CrossRef Thomas C, Kobold U, Balan S, et al. Serum hepcidin-25 may replace the ferritin index in the Thomas plot in assessing iron status in anemic patients. Int J Lab Hem. 2011;33:187–93.CrossRef
73.
Zurück zum Zitat Lee P, Gelbart T, Waalen J, et al. The anemia of aging is not associated with increased plasma hepcidin levels. Blood Cells Mol Dis. 2008;41:252–4.PubMedCrossRef Lee P, Gelbart T, Waalen J, et al. The anemia of aging is not associated with increased plasma hepcidin levels. Blood Cells Mol Dis. 2008;41:252–4.PubMedCrossRef
74.
Zurück zum Zitat Uehata T, Tomosugi N, Shoji T, et al. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study. Nephrol Dial Transplant. 2012;27:1076–83.PubMedCrossRef Uehata T, Tomosugi N, Shoji T, et al. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study. Nephrol Dial Transplant. 2012;27:1076–83.PubMedCrossRef
75.
Zurück zum Zitat Guidi GC, Lechi Santonastaso CL. Advancements in anemias related to chronic conditions. Clin Chem Lab Med. 2010;48:1217–26.PubMedCrossRef Guidi GC, Lechi Santonastaso CL. Advancements in anemias related to chronic conditions. Clin Chem Lab Med. 2010;48:1217–26.PubMedCrossRef
76.
Zurück zum Zitat Macdougall IC, Malyszko J, Hider RC, et al. Current status of the measurement of blood hepcidin levels in chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:1681–9.PubMedCrossRef Macdougall IC, Malyszko J, Hider RC, et al. Current status of the measurement of blood hepcidin levels in chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:1681–9.PubMedCrossRef
77.
Zurück zum Zitat Schwarz P, Strnad P, von Figura G, et al. A novel monoclonal antibody immunoassay for the detection of human serum hepcidin. J Gastroenterol. 2011;46:648–56.PubMedCrossRef Schwarz P, Strnad P, von Figura G, et al. A novel monoclonal antibody immunoassay for the detection of human serum hepcidin. J Gastroenterol. 2011;46:648–56.PubMedCrossRef
78.
Zurück zum Zitat Koliaraki V, Marinou M, Vassilakopoulos TP, et al. A novel immunological assay for hepcidin quantification in human serum. PLoS One. 2009;4:e4581. Koliaraki V, Marinou M, Vassilakopoulos TP, et al. A novel immunological assay for hepcidin quantification in human serum. PLoS One. 2009;4:e4581.
79.
Zurück zum Zitat Ganz T, Olbina G, Girelli D, et al. Immunoassay for human serum hepcidin. Blood. 2008;112:4292–7.PubMedCrossRef Ganz T, Olbina G, Girelli D, et al. Immunoassay for human serum hepcidin. Blood. 2008;112:4292–7.PubMedCrossRef
80.
Zurück zum Zitat Rumjon A, Sarafidis P, Brincat S, et al. Serum hemojuvelin and hepcidin levels in chronic kidney disease. Am J Mephrol. 2012;35:295–304.CrossRef Rumjon A, Sarafidis P, Brincat S, et al. Serum hemojuvelin and hepcidin levels in chronic kidney disease. Am J Mephrol. 2012;35:295–304.CrossRef
81.
Zurück zum Zitat Malyszko J. Hemojuvelin: the hepcidin story continues. Kidney Blood Press Res. 2009;32:71–6.PubMedCrossRef Malyszko J. Hemojuvelin: the hepcidin story continues. Kidney Blood Press Res. 2009;32:71–6.PubMedCrossRef
82.
Zurück zum Zitat Malyszko J, Malyszko JS, Levin-Iaina N. Is hemojuvelin a possible new player in iron metabolism in hemodialysis patients? Int Urol Nephrol. (in press). Malyszko J, Malyszko JS, Levin-Iaina N. Is hemojuvelin a possible new player in iron metabolism in hemodialysis patients? Int Urol Nephrol. (in press).
83.
Zurück zum Zitat Du X, She E, Gelbart T, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science. 2008;320:1088–92.PubMedCrossRef Du X, She E, Gelbart T, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science. 2008;320:1088–92.PubMedCrossRef
84.
Zurück zum Zitat Cau M, Melis MA, Congiu R, et al. Iron-deficiency anemia secondary to mutations in genes controlling hepcidin. Expert Rev Hematol. 2010;3:205–16.PubMedCrossRef Cau M, Melis MA, Congiu R, et al. Iron-deficiency anemia secondary to mutations in genes controlling hepcidin. Expert Rev Hematol. 2010;3:205–16.PubMedCrossRef
85.
Zurück zum Zitat Tettamanti M, Lucca U, Gandini F, et al. Prevalence, incidence and types of mild anaemia in the elderly: the “Health and Anaemia” population-based study. Haematologica. 2010;95:1849–56.PubMedCrossRef Tettamanti M, Lucca U, Gandini F, et al. Prevalence, incidence and types of mild anaemia in the elderly: the “Health and Anaemia” population-based study. Haematologica. 2010;95:1849–56.PubMedCrossRef
86.
Zurück zum Zitat Bassett ML, Goulston KJ. False positive and negative hemoccult reactions on a normal diet and effect of diet restriction. Aust N Z J Med. 1980;10:1–4.PubMedCrossRef Bassett ML, Goulston KJ. False positive and negative hemoccult reactions on a normal diet and effect of diet restriction. Aust N Z J Med. 1980;10:1–4.PubMedCrossRef
87.
Zurück zum Zitat Macrae FA, St John DJ, Caligiore P, et al. Optimal dietary conditions for hemoccult testing. Gastroenterology. 1982;82:899–903.PubMed Macrae FA, St John DJ, Caligiore P, et al. Optimal dietary conditions for hemoccult testing. Gastroenterology. 1982;82:899–903.PubMed
88.
Zurück zum Zitat Delco F, Sonnenberg A. Limitations of the faecal occult blood test in screening for colorectal cancer. Ital J Gastroenterol Hepatol. 1999;31:119–26.PubMed Delco F, Sonnenberg A. Limitations of the faecal occult blood test in screening for colorectal cancer. Ital J Gastroenterol Hepatol. 1999;31:119–26.PubMed
89.
Zurück zum Zitat Chrostek L, Cylwik B, Grszewska E, et al. The diagnostic power of direct carbohydrate-deficient transferrin immunoassay in alcoholics. Absolute or relative values? Alcohol. 2012;46:69–73.PubMedCrossRef Chrostek L, Cylwik B, Grszewska E, et al. The diagnostic power of direct carbohydrate-deficient transferrin immunoassay in alcoholics. Absolute or relative values? Alcohol. 2012;46:69–73.PubMedCrossRef
90.
Zurück zum Zitat Marsh JCW, Ball SE, Cavenagh J, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147:43–70.PubMedCrossRef Marsh JCW, Ball SE, Cavenagh J, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147:43–70.PubMedCrossRef
91.
Zurück zum Zitat Dhaliwal G, Cornett PA, Tierney LM Jr. Hemolytic anemia. Am Fam Physician. 2004;69:2599–606.PubMed Dhaliwal G, Cornett PA, Tierney LM Jr. Hemolytic anemia. Am Fam Physician. 2004;69:2599–606.PubMed
92.
Zurück zum Zitat Müller A, Zimmermann R, Krause SW. Hemolytic anemias in adults. Dtsch Med Wochenschr. 2011;136:2308–12.PubMedCrossRef Müller A, Zimmermann R, Krause SW. Hemolytic anemias in adults. Dtsch Med Wochenschr. 2011;136:2308–12.PubMedCrossRef
93.
Zurück zum Zitat Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem. 1996;42:1589–600.PubMed Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem. 1996;42:1589–600.PubMed
94.
Zurück zum Zitat Gupta S, Ahern K, Nakhl F, et al. Clinical usefulness of haptoglobin levels to evaluate hemolysis in recently transfused patients. Adv Hematol. 2011;2011:389854.PubMed Gupta S, Ahern K, Nakhl F, et al. Clinical usefulness of haptoglobin levels to evaluate hemolysis in recently transfused patients. Adv Hematol. 2011;2011:389854.PubMed
96.
Zurück zum Zitat Sadrzadeh SM, Bozorgmehr J. Haptoglobin phenotypes in health and disease. Am J Clin Pathol. 2004;121:S97–104.PubMed Sadrzadeh SM, Bozorgmehr J. Haptoglobin phenotypes in health and disease. Am J Clin Pathol. 2004;121:S97–104.PubMed
97.
Zurück zum Zitat Itzecka J. The biological role of haptoglobin and behaviour of this protein in different diseases, with special attention paid to brain stroke. Ann Univ Mariae Curie Sklodowska Med. 1996;51:115–21. Itzecka J. The biological role of haptoglobin and behaviour of this protein in different diseases, with special attention paid to brain stroke. Ann Univ Mariae Curie Sklodowska Med. 1996;51:115–21.
98.
Zurück zum Zitat Kasvosve I, Speeckaert MM, Speeckaert R, et al. Haptoglobin polymorphism and infection. Adv Clin Chem. 2010;50:23–46.PubMedCrossRef Kasvosve I, Speeckaert MM, Speeckaert R, et al. Haptoglobin polymorphism and infection. Adv Clin Chem. 2010;50:23–46.PubMedCrossRef
99.
Zurück zum Zitat Staals J, Henskens LHG, Delanghe JR, et al. Haptoglobin phenotype correlates with the extent of cerebral deep white matter lesions in hypertensive patients. Curr Neurevasc Res. 2010;7:1–5.CrossRef Staals J, Henskens LHG, Delanghe JR, et al. Haptoglobin phenotype correlates with the extent of cerebral deep white matter lesions in hypertensive patients. Curr Neurevasc Res. 2010;7:1–5.CrossRef
100.
Zurück zum Zitat Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician. 2009;79:203–8.PubMed Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician. 2009;79:203–8.PubMed
101.
Zurück zum Zitat Savage DG, Ogundipe A, Allen RH, et al. Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci. 2000;319:343–52.PubMedCrossRef Savage DG, Ogundipe A, Allen RH, et al. Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci. 2000;319:343–52.PubMedCrossRef
102.
Zurück zum Zitat Malcovati L, Della Porta MG, Strupp C, et al. Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based prognostic scoring System (WPSS). Haematologica. 2011;96:1433–40.PubMedCrossRef Malcovati L, Della Porta MG, Strupp C, et al. Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based prognostic scoring System (WPSS). Haematologica. 2011;96:1433–40.PubMedCrossRef
103.
Zurück zum Zitat Izaks GJ, Westendorp RGJ, Knook DL. The definition of anemia in older persons. JAMA. 1999;281:1714–7.PubMedCrossRef Izaks GJ, Westendorp RGJ, Knook DL. The definition of anemia in older persons. JAMA. 1999;281:1714–7.PubMedCrossRef
104.
Zurück zum Zitat Lechner K, Födinger M, Grisold W, et al. Vitamin B12 Mangel: Neue Daten zu einem alten Thema. Wien Klein Wochenschr. 2005;117:579–91.CrossRef Lechner K, Födinger M, Grisold W, et al. Vitamin B12 Mangel: Neue Daten zu einem alten Thema. Wien Klein Wochenschr. 2005;117:579–91.CrossRef
105.
Zurück zum Zitat Fragasso A, Mannarella C, Ciancio A, et al. Functional vitamin B12 deficiency in alcoholics: an intriguing finding in a retrospective study of megaloblastic anaemic patients. Eur J Intern Med. 2010;21:97–100.PubMedCrossRef Fragasso A, Mannarella C, Ciancio A, et al. Functional vitamin B12 deficiency in alcoholics: an intriguing finding in a retrospective study of megaloblastic anaemic patients. Eur J Intern Med. 2010;21:97–100.PubMedCrossRef
106.
Zurück zum Zitat Drammeh BS, Schleicher RL, Pfeiffer CM, et al. Effects of delayed sample processing and freezing on serum concentrations of selected nutritional indicators. Clin Chem. 2008;54:1883–91.PubMedCrossRef Drammeh BS, Schleicher RL, Pfeiffer CM, et al. Effects of delayed sample processing and freezing on serum concentrations of selected nutritional indicators. Clin Chem. 2008;54:1883–91.PubMedCrossRef
107.
Zurück zum Zitat Hustad S, Eussen S, Midttun Ø, et al. Kinetic modelling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism. Clin Chem. 2012;58:402–10.PubMedCrossRef Hustad S, Eussen S, Midttun Ø, et al. Kinetic modelling of storage effects on biomarkers related to B vitamin status and one-carbon metabolism. Clin Chem. 2012;58:402–10.PubMedCrossRef
108.
Zurück zum Zitat Varela-Moreiras G, Murphy MM, Scott JM. Cobalamin, folic acid, and homocysteine. Nutr Rev. 2009;67:S69–72.PubMedCrossRef Varela-Moreiras G, Murphy MM, Scott JM. Cobalamin, folic acid, and homocysteine. Nutr Rev. 2009;67:S69–72.PubMedCrossRef
109.
Zurück zum Zitat Klee GG. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs Vitamin B(12) and folate. Clin Chem. 2000;46:1277–83.PubMed Klee GG. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs Vitamin B(12) and folate. Clin Chem. 2000;46:1277–83.PubMed
110.
Zurück zum Zitat Carmel R, Green R, Rosenblatt DS, et al. Update on cobalamin, folate, and homocystein. Hematology Am Soc Hematol Educ Program. 2003:62–81. Carmel R, Green R, Rosenblatt DS, et al. Update on cobalamin, folate, and homocystein. Hematology Am Soc Hematol Educ Program. 2003:62–81.
111.
Zurück zum Zitat Lindenbaum J. Status of laboratory testing in the diagnosis of megaloblastic anemia. Blood. 1983;61:624–7.PubMed Lindenbaum J. Status of laboratory testing in the diagnosis of megaloblastic anemia. Blood. 1983;61:624–7.PubMed
112.
113.
Zurück zum Zitat Lahner E, Annibale B. Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol. 2009;15:5121–8.PubMedCrossRef Lahner E, Annibale B. Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol. 2009;15:5121–8.PubMedCrossRef
114.
Zurück zum Zitat Presotto F, Sabini B, Cecchetto A, et al. Helicobacter pylori infection and gastric autoimmune diseases: is there a link? Helicobacter. 2003;8:578–84.PubMedCrossRef Presotto F, Sabini B, Cecchetto A, et al. Helicobacter pylori infection and gastric autoimmune diseases: is there a link? Helicobacter. 2003;8:578–84.PubMedCrossRef
Metadaten
Titel
Diagnosis of anaemia: old things rearranged
verfasst von
Prim. Univ.-Prof. Dr. Gabriele Halwachs-Baumann, MSc, MBA
Publikationsdatum
01.11.2012
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 21-22/2012
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-012-0149-1

Weitere Artikel der Ausgabe 21-22/2012

Wiener Medizinische Wochenschrift 21-22/2012 Zur Ausgabe

editorial

Biomarkers